These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

171 related articles for article (PubMed ID: 38283360)

  • 1. Mutational analysis of SARS-CoV-2 ORF6-KPNA2 binding interface and identification of potent small molecule inhibitors to recuse the host immune system.
    Suleman M; Said A; Khan H; Rehman SU; Alshammari A; Crovella S; Yassine HM
    Front Immunol; 2023; 14():1266776. PubMed ID: 38283360
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Elucidating the binding mechanism of SARS-CoV-2 NSP6-TBK1 and structure-based designing of phytocompounds inhibitors for instigating the host immune response.
    Suleman M; Ishaq I; Khan H; Ullah Khan S; Masood R; Albekairi NA; Alshammari A; Crovella S
    Front Chem; 2023; 11():1346796. PubMed ID: 38293247
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Abrogation of ORF8-IRF3 binding interface with Carbon nanotube derivatives to rescue the host immune system against SARS-CoV-2 by using molecular screening and simulation approaches.
    Suleman M; Murshed A; Imran K; Khan A; Ali Z; Albekairi NA; Wei DQ; Yassine HM; Crovella S
    BMC Chem; 2024 May; 18(1):99. PubMed ID: 38734638
    [TBL] [Abstract][Full Text] [Related]  

  • 4. SARS-CoV-2 ORF6 protein does not antagonize interferon signaling in respiratory epithelial Calu-3 cells during infection.
    Li M; Ayyanathan K; Dittmar M; Miller J; Tapescu I; Lee JS; McGrath ME; Xue Y; Vashee S; Schultz DC; Frieman MB; Cherry S
    mBio; 2023 Aug; 14(4):e0119423. PubMed ID: 37377442
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Computational exploration of the dual role of the phytochemical fortunellin: Antiviral activities against SARS-CoV-2 and immunomodulatory abilities against the host.
    Agrawal S; Pathak E; Mishra R; Mishra V; Parveen A; Mishra SK; Byadgi PS; Dubey SK; Chaudhary AK; Singh V; Chaurasia RN; Atri N
    Comput Biol Med; 2022 Oct; 149():106049. PubMed ID: 36103744
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Molecular modelling identification of phytocompounds from selected African botanicals as promising therapeutics against druggable human host cell targets of SARS-CoV-2.
    Uhomoibhi JO; Shode FO; Idowu KA; Sabiu S
    J Mol Graph Model; 2022 Jul; 114():108185. PubMed ID: 35430474
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Evasion of Type I Interferon by SARS-CoV-2.
    Xia H; Cao Z; Xie X; Zhang X; Chen JY; Wang H; Menachery VD; Rajsbaum R; Shi PY
    Cell Rep; 2020 Oct; 33(1):108234. PubMed ID: 32979938
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Computational Determination of Potential Multiprotein Targeting Natural Compounds for Rational Drug Design Against SARS-COV-2.
    Muhseen ZT; Hameed AR; Al-Hasani HMH; Ahmad S; Li G
    Molecules; 2021 Jan; 26(3):. PubMed ID: 33525411
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Molecular screening of glycyrrhizin-based inhibitors against ACE2 host receptor of SARS-CoV-2.
    Ahmad S; Waheed Y; Abro A; Abbasi SW; Ismail S
    J Mol Model; 2021 Jun; 27(7):206. PubMed ID: 34169390
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Computational screening of natural products to identify potential inhibitors for human neuropilin-1 (NRP1) receptor to abrogate the binding of SARS-CoV-2 and host cell.
    Karkashan A; Attar R
    J Biomol Struct Dyn; 2023 Nov; 41(19):9987-9996. PubMed ID: 36437796
    [TBL] [Abstract][Full Text] [Related]  

  • 11. SARS-CoV-2 M
    Bharadwaj S; Azhar EI; Kamal MA; Bajrai LH; Dubey A; Jha K; Yadava U; Kang SG; Dwivedi VD
    J Biomol Struct Dyn; 2022 Apr; 40(6):2769-2784. PubMed ID: 33150855
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Virtual Screening of
    Miandad K; Ullah A; Bashir K; Khan S; Abideen SA; Shaker B; Alharbi M; Alshammari A; Ali M; Haleem A; Ahmad S
    Molecules; 2022 Nov; 27(22):. PubMed ID: 36432204
    [TBL] [Abstract][Full Text] [Related]  

  • 13. SARS-CoV-2 ORF6 disrupts nucleocytoplasmic trafficking to advance viral replication.
    Miyamoto Y; Itoh Y; Suzuki T; Tanaka T; Sakai Y; Koido M; Hata C; Wang CX; Otani M; Moriishi K; Tachibana T; Kamatani Y; Yoneda Y; Okamoto T; Oka M
    Commun Biol; 2022 May; 5(1):483. PubMed ID: 35590097
    [TBL] [Abstract][Full Text] [Related]  

  • 14.
    Maurya AK; Mishra N
    J Biomol Struct Dyn; 2021 Nov; 39(18):7306-7321. PubMed ID: 32835632
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Identification of potential natural inhibitors of the receptor-binding domain of the SARS-CoV-2 spike protein using a computational docking approach.
    Mathew SM; Benslimane F; Althani AA; Yassine HM
    Qatar Med J; 2021; 2021(1):12. PubMed ID: 34604010
    [No Abstract]   [Full Text] [Related]  

  • 16. Development of Effective Therapeutic Molecule from Natural Sources against Coronavirus Protease.
    Fadaka AO; Sibuyi NRS; Martin DR; Klein A; Madiehe A; Meyer M
    Int J Mol Sci; 2021 Aug; 22(17):. PubMed ID: 34502340
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Repurposing immune boosting and anti-viral efficacy of
    Dinata R; Nisa N; Arati C; Rasmita B; Uditraj C; Siddhartha R; Bhanushree B; Saeed-Ahmed L; Manikandan B; Bidanchi RM; Abinash G; Pori B; Khushboo M; Roy VK; Gurusubramanian G
    J Biomol Struct Dyn; 2024; 42(1):43-81. PubMed ID: 37021347
    [TBL] [Abstract][Full Text] [Related]  

  • 18. An In silico Investigation to Identify Promising Inhibitors for SARS-CoV-2 M
    Alagarsamy V; Sundar PS; Narendhar B; Sulthana MT; Kulkarni VS; Aishwarya AD; Solomon VR; Murugesan S; Jubie S; Rohitha K; Dhanwar S
    Med Chem; 2023; 19(9):925-938. PubMed ID: 37069723
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Rescuing the Host Immune System by Targeting the Immune Evasion Complex ORF8-IRF3 in SARS-CoV-2 Infection with Natural Products Using Molecular Modeling Approaches.
    Albutti A
    Int J Environ Res Public Health; 2021 Dec; 19(1):. PubMed ID: 35010372
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparative mutational analysis of SARS-CoV-2 isolates from Pakistan and structural-functional implications using computational modelling and simulation approaches.
    Shah A; Rehmat S; Aslam I; Suleman M; Batool F; Aziz A; Rashid F; Midrarullah ; Nawaz MA; Ali SS; Junaid M; Khan A; Wei DQ
    Comput Biol Med; 2022 Feb; 141():105170. PubMed ID: 34968862
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.